Impact of auricular percutaneous electrical nerve field stimulation on gut microbiome in adolescents with irritable bowel syndrome: A pilot study
Journal of Digestive Diseases · 2023
DOI: 10.1111/1751-2980.13203 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Digestive Diseases, 2023. Verfasst von Geetanjali Bora und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Gastrointestinal Microbiome. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 131 Literaturangaben.
Abstract (Originalsprache)
Objectives
Percutaneous electrical nerve field stimulation (PENFS) has documented efficacy for irritable bowel syndrome (IBS) via plausible vagal neuromodulation effects. The vagus nerve may affect gut microbiome composition via brain–gut–microbiome signaling. We aimed to investigate gut microbiome alterations by PENFS therapy in adolescent IBS patients.
Methods
A prospective study of females with IBS aged 11–18 years receiving PENFS therapy for 4 weeks with pre‐ and post‐intervention stool sampling was conducted. Outcome surveys completed pre‐therapy, weekly, and post‐therapy included IBS‐Severity Scoring System (IBS‐SSS), Visceral Sensitivity Index (VSI), Functional Disability Inventory (FDI), and the global symptom response scale (SRS). Bacterial DNA was extracted from stool samples followed by 16S rRNA amplification and sequencing. QIIME 2 (version 2022.2) was used for analyses of α and β diversity and differential abundance by group.
Results
Twenty females aged 15.6 ± 1.62 years were included. IBS‐SSS, VSI, and FDI scores decreased significantly after PENFS therapy ( P < 0.0001, P = 0.0003, P = 0.0004, respectively). No intra‐ or interindividual microbiome changes were noted pre‐ versus post‐therapy or between responders and non‐responders. When response was defined by 50‐point IBS‐SSS score reduction, α diversity was higher in responders compared with non‐responders at week 4 ( P = 0.033). There was higher abundance of Blautia in excellent responders versus non‐responders.
Conclusions
There were no substantial microbial diversity alterations with PENFS. Subjects with excellent therapeutic response showed an enrichment of relative abundance of Blautia , which may indicate that patients with specific microbial signature have a more favorable response to PENFS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- Center for Microbiome Research, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- Divison of Quantitative Health Sciences, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- Division of Pediatric Gastroenterology, Department of Pediatrics, University of Illinois College of Medicine Peoria, Peoria, Illinois, USA.
Zitieren
APA
Bora, G., Atkinson, S. N., Pan, A., Sood, M., Salzman, N., & Karrento, K. (2023). Impact of auricular percutaneous electrical nerve field stimulation on gut microbiome in adolescents with irritable bowel syndrome: A pilot study. Journal of Digestive Diseases. https://doi.org/10.1111/1751-2980.13203
Vancouver
Bora G, Atkinson SN, Pan A, Sood M, Salzman N, Karrento K. Impact of auricular percutaneous electrical nerve field stimulation on gut microbiome in adolescents with irritable bowel syndrome: A pilot study. Journal of Digestive Diseases. 2023. doi:10.1111/1751-2980.13203
BibTeX
@article{Bora2023,
author = {Bora, Geetanjali and Atkinson, Samantha N and Pan, Amy and Sood, Manu and Salzman, Nita and Karrento, Katja},
title = {Impact of auricular percutaneous electrical nerve field stimulation on gut microbiome in adolescents with irritable bowel syndrome: A pilot study},
journal = {Journal of Digestive Diseases},
year = {2023},
doi = {10.1111/1751-2980.13203}
}
EUVIMED